Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

ImmuCell Corporation

Contributing Author

Recent Articles by ImmuCell Corporation

Aug-13
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 ICCC ICCC -7.80% GlobeNewswire
Aug-06
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026 ICCC GlobeNewswire
Jul-09
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results ICCC +7.76% GlobeNewswire
May-14
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 ICCC ICCC +7.99% GlobeNewswire
May-07
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 ICCC GlobeNewswire
Apr-13
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors ICCC ICCC +8.72% GlobeNewswire
Apr-08
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results ICCC ICCC +12.70% GlobeNewswire
Mar-18
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board ICCC GlobeNewswire
Mar-04
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 ICCC GlobeNewswire
Feb-18
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 ICCC GlobeNewswire
Jan-08
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 ICCC +5.29% GlobeNewswire
Jan-07
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus ICCC GlobeNewswire
Dec-24
ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain ICCC ICCC +5.52% GlobeNewswire
Nov-13
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 ICCC ICCC -10.74% GlobeNewswire
Nov-06
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 ICCC GlobeNewswire
Nov-04
ImmuCell Announces Onboarding of New CEO and Related Management Changes ICCC ICCC +5.00% GlobeNewswire
Oct-07
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 ICCC GlobeNewswire
Sep-29
ImmuCell Announces Selection of its Next President and CEO ICCC GlobeNewswire
Aug-14
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 ICCC ICCC -9.18% GlobeNewswire
Aug-12
ImmuCell Announces Bank Debt Refinancing ICCC GlobeNewswire
Aug-07
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025 ICCC GlobeNewswire
Jul-09
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025 ICCC GlobeNewswire
Jun-25
ImmuCell Embarks on CEO Succession Planning Process ICCC -10.78% GlobeNewswire
Jun-05
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders ICCC GlobeNewswire
May-14
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 ICCC ICCC +7.94% GlobeNewswire
May-12
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 ICCC GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)